These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18480695)

  • 21. Self-esteem in patients with borderline and avoidant personality disorders.
    Lynum LI; Wilberg T; Karterud S
    Scand J Psychol; 2008 Oct; 49(5):469-77. PubMed ID: 18564322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
    Gómez-Perretta C
    Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
    [No Abstract]   [Full Text] [Related]  

  • 23. Prediction of change in borderline personality disorder.
    Goldberg SC
    Psychopharmacol Bull; 1989; 25(4):550-5. PubMed ID: 2576568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.
    Pascual JC; Oller S; Soler J; Barrachina J; Alvarez E; Pérez V
    J Clin Psychiatry; 2004 Sep; 65(9):1281-2. PubMed ID: 15367057
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of borderline personality disorder with risperidone.
    Rocca P; Marchiaro L; Cocuzza E; Bogetto F
    J Clin Psychiatry; 2002 Mar; 63(3):241-4. PubMed ID: 11926724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.
    Sahoo S; Mishra B; Akhtar S
    Br J Clin Pharmacol; 2007 Nov; 64(5):715-6. PubMed ID: 17509037
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder.
    Hough DW
    J Clin Psychiatry; 2001 Apr; 62(4):296-7. PubMed ID: 11379847
    [No Abstract]   [Full Text] [Related]  

  • 28. Borderline personality features in childhood: a short-term longitudinal study.
    Crick NR; Murray-Close D; Woods K
    Dev Psychopathol; 2005; 17(4):1051-70. PubMed ID: 16613430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Abuse of quetiapine. Two addicted patients with borderline personality disorder].
    Galyuk TM; de Backer G; de Jong CA; Beers E; Loonen AJ
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):674-6. PubMed ID: 19425328
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychic structure: exploring an empirically still unknown territory.
    Klug G; Huber D
    J Am Psychoanal Assoc; 2009 Feb; 57(1):149-73. PubMed ID: 19270249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
    American Psychiatric Association Practice Guidelines
    Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder.
    Carrasco JL; Palomares N; Marsá MD
    Psychopharmacology (Berl); 2012 Nov; 224(2):347-8. PubMed ID: 23052570
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose risperidone for pathological jealousy: report of 3 cases.
    Bisol LW; Lara DR
    J Clin Psychopharmacol; 2008 Oct; 28(5):595-6. PubMed ID: 18794672
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopharmacologic approaches to the borderline patient.
    Zisook S; Ricketts JE
    Hillside J Clin Psychiatry; 1988; 10(1):55-70. PubMed ID: 2900799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone-associated increase in triglyceride levels.
    Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
    Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
    [No Abstract]   [Full Text] [Related]  

  • 38. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):161-2. PubMed ID: 11285097
    [No Abstract]   [Full Text] [Related]  

  • 40. Can assessors and therapists predict the outcome of long-term psychotherapy in borderline personality disorder?
    Spinhoven P; Giesen-Bloo J; van Dyck R; Arntz A
    J Clin Psychol; 2008 Jun; 64(6):667-86. PubMed ID: 18384120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.